Search | IOVS | ARVO Journals

Showing 1 – 20 of 37

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Clinical utility of Spectral-Domain Optical Coherence Tomography (SD-OCT) marker Disorganization of Retinal Inner Layers (DRIL) in Diabetic Retinopathy (DR)

Srinidhi Singuri; Shiming Luo; Dilara Hatipoglu; Amy Nowacki; Riya Patel; Andrew Schachat; Aleksandra V Rachitskaya; Justis P Ehlers; Sumit Sharma; Peter K Kaiser; Sunil K Srivastava; Elias I Traboulsi; Daniel F Martin; Rishi P Singh; Bela Anand-Apte; Alex Yuan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2517 – F0243.

ARVO Annual Meeting Abstract June 2020

Presentation and outcomes of patients with post-injection endophthalmitis at a large academic center

Michael Ramos; Srinidhi Singuri; Lucy Xu; Julio Castillo; Justis P Ehlers; Peter M Kaiser; Rishi P Singh; Aleksandra Rachitskaya; Sunil K Srivastava; Jonathan E Sears; Andrew Schachat; Amy Babiuch; Sumit Sharma; Daniel F Martin; Careen Y Lowder; Alex Yuan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4410.

ARVO Annual Meeting Abstract July 2019

Incidence and Features of Geographic Atrophy in Fellow Eyes in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT)

Delu Song; Gui-Shuang Ying; Juan E Grunwald; Ebenezer Daniel; Maureen G Maguire; Yafeng Li; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1144.

ARVO Annual Meeting Abstract July 2018

Association between Oral Iron Supplementation and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials

Delu Song; Gui-Shuang Ying; Joshua L Dunaief; Rupak Bhuyan; Yafeng Li; Maureen G. Maguire; Juan E Grunwald; Ebenezer Daniel; Stephanie A Hagstrom; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2396.

ARVO Annual Meeting Abstract July 2018

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Benjamin J Kim; Wei Pan; Juan E Grunwald; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; Maureen G. Maguire

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3252.

ARVO Annual Meeting Abstract June 2017

Characteristics of Patients with Good Visual Acuity at 5 Years Despite No Treatment after 2 Years in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Daniel F Martin; Stuart L Fine; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn J Jaffe; Cynthia A Toth; Gui-Shuang Ying; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1196.

ARVO Annual Meeting Abstract June 2017

Development of geographic atrophy in age-related macular degeneration treated with long term intravitreal injections of anti-vascular endothelial growth factor.

Ang Li; Fabiana Queiroga de Paula Araujo Silva; Jonathan E Sears; Sunil K Srivastava; Justis Ehlers; Andrew Schachat; Peter K Kaiser; Daniel F Martin; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):897.

ARVO Annual Meeting Abstract June 2017

Comparison of efficacy and safety of intravitreal triamcinolone acetonide vs dexamethasone implant (Ozurdex) in treatment of diabetic macular edema

Rachel C Chen; Justis Ehlers; Rishi P Singh; Sunil K Srivastava; Daniel F Martin; Andrew Schachat; Jonathan E Sears; Alex Yuan; Amy Shrader Babiuch; Peter K Kaiser

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):921.

ARVO Annual Meeting Abstract June 2017

Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Cynthia A Toth; Vincent Tai; Maxwell Pistilli; Stephanie Chiu; Katrina Winter; Ebenezer Daniel; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Gui-Shuang Ying; Sina Farsiu; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1195.

ARVO Annual Meeting Abstract June 2017

Incidence and risk factors for neovascular AMD in the fellow eye in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Maureen G Maguire; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn Jay Jaffe; Cynthia A Toth; Stephanie A Hagstrom; Gui-Shuang Ying; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2323.

ARVO Annual Meeting Abstract June 2017

Risk factors for retinal scar development in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Maureen G Maguire; Wei Pan; Cynthia A Toth; Glenn Jay Jaffe; Daniel F Martin; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2337.

ARVO Annual Meeting Abstract June 2017

Associations of retinal and choroidal thickness with visual acuity at year 5 in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT)

Wenlan Zhang; Gui-Shuang Ying; Daniel F Martin; Maureen G Maguire; Cynthia A Toth; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3403.

ARVO Annual Meeting Abstract June 2017

Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Vincent Tai; Stephanie Chiu; Katrina Winter; Ebenezer Daniel; Juan E Grunwald; Maxwell Pistilli; Monica Sevilla; Gui-Shuang Ying; Glenn J Jaffe; Daniel F Martin; Sina Farsiu; Maureen G Maguire; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):870.

ARVO Annual Meeting Abstract June 2017

Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT)

Gui-Shuang Ying; Maureen G Maguire; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):886.

ARVO Annual Meeting Abstract September 2016

Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Juan E Grunwald; Maxwell Pistilli; Ebenezer Daniel; Gui-Shuang Ying; Glenn J Jaffe; Stuart L Fine; Daniel F Martin; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Pseudodrusen and Incidence of Late Age-related Macular Degeneration (AMD) in Fellow Eyes in the Comparison of AMD Treatments Trials (CATT)

Qiang Zhou; Ebenezer Daniel; Maureen G Maguire; Juan E Grunwald; Revell Martin; Daniel F Martin; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; James A Shaffer; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin; Frederick L Ferris; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2653.

ARVO Annual Meeting Abstract June 2015

Resolution of Retinal Fluid on Optical Coherence Tomography in the Comparison of AMD Treatments Trials (CATT)

Maxwell Pistilli; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1657.

ARVO Annual Meeting Abstract June 2015

Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Maureen G Maguire; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2833.

ARVO Annual Meeting Abstract June 2015

Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Neepa Shah; Maureen G Maguire; Daniel F Martin; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Cynthia A Toth; Glenn J Jaffe; Ebenezer Daniel; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2847.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Clinical utility of Spectral-Domain Optical Coherence Tomography (SD-OCT) marker Disorganization of Retinal Inner Layers (DRIL) in Diabetic Retinopathy (DR)

Presentation and outcomes of patients with post-injection endophthalmitis at a large academic center

Incidence and Features of Geographic Atrophy in Fellow Eyes in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT)

Association between Oral Iron Supplementation and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Characteristics of Patients with Good Visual Acuity at 5 Years Despite No Treatment after 2 Years in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Development of geographic atrophy in age-related macular degeneration treated with long term intravitreal injections of anti-vascular endothelial growth factor.

Comparison of efficacy and safety of intravitreal triamcinolone acetonide vs dexamethasone implant (Ozurdex) in treatment of diabetic macular edema

Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Incidence and risk factors for neovascular AMD in the fellow eye in the Comparison of AMD Treatment Trials (CATT) Follow-up Study

Risk factors for retinal scar development in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Associations of retinal and choroidal thickness with visual acuity at year 5 in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT)

Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT)

Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Pseudodrusen and Incidence of Late Age-related Macular Degeneration (AMD) in Fellow Eyes in the Comparison of AMD Treatments Trials (CATT)

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Resolution of Retinal Fluid on Optical Coherence Tomography in the Comparison of AMD Treatments Trials (CATT)

Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

To View More...

You must be signed into an individual account to use this feature.